212 related articles for article (PubMed ID: 20802330)
1. Adverse effects of proton pump inhibitor drugs: clues and conclusions.
McCarthy DM
Curr Opin Gastroenterol; 2010 Nov; 26(6):624-31. PubMed ID: 20802330
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors: potential adverse effects.
Abraham NS
Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
[TBL] [Abstract][Full Text] [Related]
3. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
Hauben M; Horn S; Reich L; Younus M
Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
[TBL] [Abstract][Full Text] [Related]
4. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of proton pump inhibitors.
Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile.
Baierlein SA; Wistop A
N Engl J Med; 2009 Feb; 360(6):636-7; author reply 637-8. PubMed ID: 19202581
[No Abstract] [Full Text] [Related]
7. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
9. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
Fournier MR; Targownik LE; Leslie WD
Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
[TBL] [Abstract][Full Text] [Related]
11. Considerations for the use of proton-pump inhibitors in older adults.
Desilets AR; Asal NJ; Dunican KC
Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
[TBL] [Abstract][Full Text] [Related]
12. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
13. [Potential risks associated with long-term PPI use].
Kamiya T
Nihon Rinsho; 2016 Aug; 74(8):1387-1391. PubMed ID: 30562448
[TBL] [Abstract][Full Text] [Related]
14. [Proton pump inhibitors and infection risk].
Palencia-Herrejón E; Sánchez B; Escobar I; Gómez-Lus ML
Rev Esp Quimioter; 2011 Mar; 24(1):4-12. PubMed ID: 21412664
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
[TBL] [Abstract][Full Text] [Related]
16. Safety of proton pump inhibitor exposure.
Yang YX; Metz DC
Gastroenterology; 2010 Oct; 139(4):1115-27. PubMed ID: 20727892
[TBL] [Abstract][Full Text] [Related]
17. Infection in solid-organ transplant recipients.
Cross TJ; Berry PA; Burroughs AK
N Engl J Med; 2008 Mar; 358(12):1302. PubMed ID: 18354113
[No Abstract] [Full Text] [Related]
18. Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
Tan VP; Yan BP; Hunt RH; Wong BC
J Gastroenterol Hepatol; 2010 Aug; 25(8):1342-7. PubMed ID: 20659222
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection: managing the risks.
DeDea L
JAAPA; 2012 May; 25(5):16. PubMed ID: 22712142
[No Abstract] [Full Text] [Related]
20. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
